Flexible solutions. Responsive teams. Data-driven insights.
With personalized medicine at the forefront of healthcare today, Medical Affairs is a logical and essential strategic leader. Medical Affairs is the owner of the scientific narrative and the trusted voice for communicating it to all stakeholders. The function champions health equity in the development and delivery of healthcare innovation, and leads cross-functional engagement of both internal and external diverse participants.
In short, Medical Affairs needs to serve as the proverbial “glue” — building alignment and powering collaboration across research and development and commercial teams.
These important roles for Medical Affairs hold true within any life sciences organization — from the largest, most established companies to emerging biopharma (EBPs). Fortunately for EBPs, effective Medical Affairs work doesn’t depend on size or scale; rather, it requires an organizational commitment to starting early, and investing energy and attention throughout the lifecycle.
In a recent webinar, IQVIA highlighted critical success factors for any EBP seeking to lead as the trusted medical voice in a complex environment — and took a closer look at the need to orchestrate engagement of relevant experts.
What does it take to power an effective Medical Affairs function? Based on the collective experience and expertise of our IQVIA team, we have identified these best practices:
As we explored during the webinar, there are a few “must do’s” for Medical Affairs teams today when planning and orchestrating engagement with key leaders:
For EBPs, effective expert engagement starts with an early, clear strategy that defines the “why” and communicates it to key stakeholders. Experience suggests it’s best not to let “great” get in the way of “good” when crafting a strategy. With that strategy in place, Medical Affairs should begin considering the types of key opinion leaders (KOLs) and their strengths — from clinical expertise to social media influence.
It’s critical to start translating the “why” into messages for the various KOL segments. From there, start creating 18+-month plans for at least 15 to 20 KOLs. Remember: Just because you have identified a KOL does not mean you must engage with them immediately. Finally, build a mechanism for studying initial engagements. What worked? What didn’t? Use those insights to expand the KOL roster strategically over time.
While expert engagement planning must be purposeful and deliver organization-wide impact, it doesn’t have to be complicated or expensive. To learn more about how to drive success in your EBP, watch the webinar replay.
Flexible solutions. Responsive teams. Data-driven insights.
U.S. Medical Affairs leverages therapeutic expertise to demonstrate the value of your therapy more effectively.